Injectable ‘Satellite Livers’ Offer Hope for Patients Awaiting Transplant

CAMBRIDGE / LONDON (IT BOLTWISE) – Researchers at MIT have developed an innovative solution for patients with liver failure: injectable mini-livers. This technology could shorten the waiting time for a transplant and offer fresh hope for thousands of patients.

The Challenge of Liver Failure and Transplantation

More than 10,000 Americans are currently waiting for a liver transplant, according to MIT researchers [1]. The shortage of donor organs creates a critical need for alternative treatments.

How ‘Satellite Livers’ Function

The new approach involves injecting “satellite livers” – mini-organs consisting of hepatocytes (liver cells) embedded in a biologically compatible hydrogel matrix. This matrix stabilizes the cells within the body and encourages the formation of connections with surrounding blood vessels [1]. The hydrogel microspheres act like a liquid during injection, allowing passage through a syringe, and then solidify once inside the body.

Promising Results in Preclinical Studies

Initial studies conducted on mice have demonstrated the functionality of these injected tissue transplants. Researchers observed the production of key enzymes and proteins normally produced by natural livers. Importantly, these transplants remained functional for at least eight weeks [1]. To further enhance cell survival and blood vessel growth, the researchers as well included fibroblasts in the injected mixture.

Potential Applications and Future Directions

This technology holds promise not only as an alternative to traditional surgical transplantation but also as a temporary bridge to maintain patients alive until a donor organ becomes available. It could also be a life-saving option for patients who are ineligible for a transplant due to other medical conditions [1].

Future research may focus on developing “stealthy” hepatocytes that avoid immune rejection or hydrogel spheres capable of locally releasing immunosuppressants.

What is INSITE?

The researchers utilized a technique called Injected, Self-assembled, Image-guided Tissue Ensembles (INSITE). This involves a mixture of hepatocytes and hydrogel microspheres that assemble in situ after injection, forming supportive scaffolds. Ultrasound guidance ensures precise placement of the graft, and blood vessels grow into the graft over time, integrating the cells with the host’s circulation [1].